Skip to content

Rapid HIV Testing for Emergency Department Patients

Rapid HIV Testing for Emergency Department Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00676481
Enrollment
570
Registered
2008-05-13
Start date
2004-07-31
Completion date
2009-06-30
Last updated
2015-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

Patient Education, Emergency Medicine, HIV Prevention, HIV Seronegativity

Brief summary

The purpose of this study is to test data collection options in emergency departments (EDs) and to enhance ED patient awareness of the risk of HIV infection.

Detailed description

Rapid HIV testing is a new technology that speeds receipt of HIV test results. Its use in EDs has been demonstrated, but patient acceptance of rapid testing in the ED has not been optimal. It is likely that the low acceptance is partially due to ED patients not realizing the risk of acquiring an HIV infection or the importance of knowing their HIV status. The purpose of this study is to test data collection options in EDs and to enhance ED patient awareness of the risk for HIV infection. This three phase study will take place at the Rhode Island Hospital Emergency Department. Each participant will be followed for the duration of their ED visit. In Phase I, the proportion of participants who are willing to undergo rapid HIV testing in the ED will be measured. Additionally, the HIV testing history of these participants, their reasons for undergoing testing or for never having been tested for HIV, and factors associated with acceptance or decline of testing and history of HIV testing will be determined. An educational video will be developed and used to investigate its effectiveness in convincing participants to have the rapid HIV test. All participants agreeing to undergo a rapid HIV test will receive a survey to complete. In Phase II, a questionnaire and feedback tool to make participants aware of their risk for an HIV infection through injection drug use and sex will be developed and investigated. In Phase III, the questionnaire and feedback tool developed in Phase II will be used to determine whether or not making participants aware of their risk for an HIV infection increases their acceptance of being tested for HIV in the ED. Participants in Arm 1 will receive the questionnaire and feedback tool while participants in Arm 2 will not.

Interventions

BEHAVIORALHIV risk education

Education for Phase III participants about potential risk of HIV infection before being asked to take a rapid HIV test in the ED

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
National Institute of Allergy and Infectious Diseases (NIAID)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* English-speaking * Subcritical illness or injury

Exclusion criteria

* Critical illness or injury * Mental or physical disability * Known HIV infection * Participation in an HIV vaccine study * Prison inmate * Acute psychiatric illness that, in the opinion of the investigator, would prevent the participant from completing the study

Design outcomes

Primary

MeasureTime frame
Willingness of participant to have HIV testingThroughout study

Secondary

MeasureTime frame
Participant comprehension of rapid HIV pre-test informationThroughout study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026